Scientists at the University of Illinois Chicago have turned an unlikely source into a potential new weapon against cancer: ...
If you're a woman newly diagnosed with breast cancer, treatment can feel ... well, scary. Will chemotherapy work? Or will it ...
A new "tumor-on-a-chip" model is giving scientists a live look at how pancreatic cancer can recruit the body's own immune ...
The goal is to close a screening gap that disproportionately affects rural communities.
Novartis is buying Myricx to internalize an NMTi-based ADC payload platform intended to expand ADC applicability and ...
Sofinnova Partners, a leading European life sciences venture capital firm, today announced that its portfolio company Myricx Bio (“Myricx”) has reached agreement to be acquired by Novartis, for up to ...
Our bodies are constantly deciding which cells should live and which should die through a process called apoptosis. This type ...
Drug developers focusing on either disease area made up more than 40% of the number of biotech companies and amount raised so ...
The new facility will enable cancer patients to take part in tailored and supervised exercise programmes, a key tool for improving their physical and emotional well-being and their tolerance of treatm ...
Find out what Novartis' pipeline strategy since it spun off its biosimilars and generics business Sandoz, and engage in ...
MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, and Bora Pharmaceuticals Co., Ltd ...
ATUM, a leading US-based contract research organization, selected to support stable clonal cell line generation to advance VERAXA’s lead BiTAC-TCE program toward IND/CTA-enabling activities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results